I agree that this site is using cookies. You can find further informations here.
X
Lorefice, L.
206  results:
OpenAccess-fulltext X
?
1

Impact of Menopause in Patients with Multiple Sclerosis: Cu..:

Lorefice L ; D'Alterio MN ; Firinu D..
https://www.dovepress.com/impact-of-menopause-in-patients-with-multiple-sclerosis-current-perspe-peer-reviewed-fulltext-article-IJWH.  , 2023
Link: https://doaj.org/article..
 
?
2

Metabolomic Changes in Patients Affected by Multiple Sclero..:

Murgia F ; Lorefice L ; Noto A...
info:eu-repo/semantics/altIdentifier/pmid/36984868.  , 2023
Link: https://hdl.handle.net/1..
 
?
3

Antibody response elicited by the SARS-CoV-2 vaccine booste..:

Schiavetti I ; Inglese M ; Frau J...
info:eu-repo/semantics/altIdentifier/pmid/37154406.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: A..:

Sormani M. P ; Schiavetti I ; Landi D...
info:eu-repo/semantics/altIdentifier/pmid/34328824.  , 2022
Link: http://hdl.handle.net/11..
 
?
5

Gut-oriented interventions in patients with multiple sclero..:

V. Martinelli ; M. Albanese ; M. Altieri...
https://www.europeanreview.org/wp/wp-content/uploads/0935-0946.pdf.  , 2022
Link: https://doaj.org/article..
 
?
6

The impact of secondary infections in COVID-19 critically i..:

Murgia F ; Fiamma M ; Serra S...
info:eu-repo/semantics/altIdentifier/pmid/35314266.  , 2022
Link: https://hdl.handle.net/1..
 
?
7

The Dimethyl Fumarate Experience: A Handy Drug With Broad C..:

Lorefice L ; Casaglia E ; Fronza M...
info:eu-repo/semantics/altIdentifier/pmid/34539545.  , 2021
Link: http://hdl.handle.net/11..
 
?
8

Effect of Different Disease-Modifying Therapies on Humoral ..:

Pitzalis M ; Idda M. L ; Lodde V...
info:eu-repo/semantics/altIdentifier/pmid/34956211.  , 2021
Link: http://hdl.handle.net/11..
 
?
9

Brain Volume and Perception of Cognitive Impairment in Peop..:

Fenu G ; Lorefice L ; Carta E...
info:eu-repo/semantics/altIdentifier/pmid/34025550.  , 2021
Link: http://hdl.handle.net/11..
 
?
10

Effect of SARS-CoV-2 mRNA vaccination in MS patients treate..:

Sormani M. P ; Schiavetti I ; Carmisciano L...
info:eu-repo/semantics/altIdentifier/pmid/34563483.  , 2021
Link: https://hdl.handle.net/1..
 
?
11

An Overview of the Efficacy and Safety of Ozanimod for the ..:

Fronza M ; Lorefice L ; Frau J.
https://www.dovepress.com/an-overview-of-the-efficacy-and-safety-of-ozanimod-for-the-treatment-o-peer-reviewed-fulltext-article-DDDT.  , 2021
Link: https://doaj.org/article..
 
?
12

Infections and Multiple Sclerosis: From the World to Sardin..:

Frau J ; Coghe G ; Lorefice L..
info:eu-repo/semantics/altIdentifier/pmid/34691035.  , 2021
Link: http://hdl.handle.net/11..
 
?
13

Effect of SARS-CoV-2 mRNA vaccination in MS patients treate..:

Sormani M. P ; Schiavetti I ; Carmisciano L...
info:eu-repo/semantics/altIdentifier/pmid/34563483.  , 2021
Link: http://hdl.handle.net/11..
 
?
14

An overview of the efficacy and safety of ozanimod for the ..:

Fronza M ; Lorefice L ; Frau J.
info:eu-repo/semantics/altIdentifier/pmid/34007159.  , 2021
Link: http://hdl.handle.net/11..
 
?
15

Harmonization of real-world studies in multiple sclerosis: ..:

Moccia M ; Annovazzi P ; Buscarinu M. C...
info:eu-repo/semantics/altIdentifier/pmid/32683308.  , 2020
Link: http://hdl.handle.net/11..
 
1-15